Methyl (S)-4-N-Cbz-piperazine-2-carboxylate

Catalog No.: 
ACBXIV860
CAS No.: 
225517-81-7
Molecular Formula: 
C14H18N2O4
Molecular Weight: 
278.31
Methyl (S)-4-N-Cbz-piperazine-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$68.00In stockInquiry
5g97%$326.00In stockInquiry
25g97%$1581.00InquiryInquiry
100g97%$4656.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl (S)-4-N-Cbz-piperazine-2-carboxylate
IUPAC Name1-benzyl 3-methyl (S)-piperazine-1,3-dicarboxylate
MDL No.MFCD04115338
Molecular FormulaC14H18N2O4
Molecular Weight278.31
SMILESO=C([C@H]1NCCN(C(OCC2=CC=CC=C2)=O)C1)OC
InChI KeyFYKXWBBQYZXPFB-LBPRGKRZSA-N
SynonymMethyl (S)-4-N-Cbz-piperazine-2-carboxylate | 1-O-benzyl 3-O-methyl (3S)-piperazine-1,3-dicarboxylate | (s)-1-benzyl 3-methyl piperazine-1,3-dicarboxylate
CAS No.225517-81-7
PubChem CID7023277

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACBXIV860 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRCEG791 route compound structure diagram
    ACRCEG7911334173-77-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBXIV860 route product structure diagram
    ACBXIV860225517-81-7In Stock
Inquiry

2. ACBXIV860 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBXIV860 route product structure diagram
    ACBXIV860225517-81-7In Stock
Inquiry

3. ACBXIV860 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBXIV860 route product structure diagram
    ACBXIV860225517-81-7In Stock
Inquiry

Comments (0)